 Design, Settings, and Participants. A randomised, double-blind, placebo-controlled trial with MDD patients allocated to two treatment arms: citalopram pindolol versus citalopram placebo. Participants: outpatients with a depressive episode DSM-IV criteria were selected from a general hospital. 